Bally’s Intralot shareholders have approved resolutions needed to advance the £243.1 million acquisition of evoke, clearing the buyer-side shareholder condition for the proposed takeover.
The general meeting on Sept. 18 authorised Intralot’s board to increase the company’s share capital and approved related amendments to its articles of association. A company announcement published through Investegate said this satisfied Condition 3(a)(i) of the scheme document.
The share-capital authorisation won 99.585% of valid votes, with 0.415% against. The two articles resolutions each passed with 99.999% support. The meeting was attended by 102 shareholders representing about 1.36 billion shares, or 72.89% of Intralot’s share capital eligible for the quorum.
The vote follows evoke shareholders’ overwhelming approval of the transaction in August, as we reported at the time. Evoke’s general meeting passed the special resolution needed to implement the scheme with 99.63% support.
The acquisition, agreed on June 5, is structured as a Gibraltar scheme of arrangement. Evoke shareholders are due to receive 0.537 new Bally’s Intralot shares for each evoke share, although they may elect a cash alternative of 52 pence per share. Total cash elections are capped at £117.1 million.
Regulatory work remains unfinished. The Jersey Competition Regulatory Authority formally opened its review on Sept. 14 under the Competition (Jersey) Law 2005. The notice is an application, rather than a clearance, and the regulator has neither announced a decision nor set a timetable. The deal also has merger-control processes in Austria and the UK, alongside gaming approvals in the UK, Italy, Germany, Gibraltar, Malta, Canada and three US states.
The companies said a number of antitrust and regulatory conditions had been met, without identifying them. Once the remaining conditions are resolved, the Gibraltar court must sanction the scheme. The court hearing and completion remain expected in the fourth quarter of 2026 or first quarter of 2027.
